Today

Agents

Chat

Arena

Discover

More

App

Aptevo Therapeutics held annual shareholder meeting

APVO•2026-08-21

Annual shareholder meeting results

Aptevo Therapeutics held its annual stockholders meeting on Aug. 21, 2026, with shareholders voting on several governance items.

Shareholders ratified Baker Tilly US, LLP as independent registered public accounting firm for the year ending Dec. 31, 2026.
Shareholders approved the Fourth Amended and Restated 2018 Stock Incentive Plan, authorizing the plan’s adoption subject to implementation.
Two director nominees were selected to serve until the 2029 annual meeting, reflecting shareholder support for the board slate.

Related News

Phillips 66 ups committed receivables financing facility to $2 billion, extends maturity to August 2027

PSX•2026-08-21

Heritage Insurance Zephyr Insurance President Timothy E. Johns disposes of 3,500 common shares worth $117,864.25

HRTG•2026-08-21

Liquidia director Katherine Rielly-Gauvin reports common share sale worth $4.08 million

Sources

S

Aptevo Therapeutics held annual shareholder meeting

Sec

LQDA•2026-08-21

Cytek wins on most Beckman patent claims; jury awards $56 million damages on remaining count

CTKB•2026-08-21

Columbus Circle Capital II Says Elroy Air Awarded Up To $46 Million US Army Contract

CMII•2026-08-21

Aptevo Therapeutics held annual shareholder meeting - APVO News | Rallies